Factor V and Thrombotic Disease Description of a Janus-Faced ...

538 Arterioscler Thromb Vasc Biol. April 2002
99. Zehnder JL, Jain M. Recurrent thrombosis due to compound heterozygosity
for factor V Leiden and factor V deficiency. Blood Coagul
Fibrinolysis. 1996;7:361–362.
100. Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D,
Girolami A. “Pseudo homozygous” activated protein C resistance due
to double heterozygous factor V defects (factor V Leiden mutation and
type I quantitative factor V defect) associated with thrombosis: report
of two cases belonging to two unrelated kindreds. Thromb Haemost.
1996;75:422–426.
101. Guasch JF, Lensen RP, Bertina RM. Molecular characterization of a
type I quantitative factor V deficiency in a thrombosis patient that is
“pseudo homozygous” for activated protein C resistance. Thromb
Haemost. 1997;77:252–257.
102. Castaman G, Lunghi B, Missiaglia E, Bernardi F, Rodeghiero F.
Phenotypic homozygous activated protein C resistance associated
with compound heterozygosity for Arg506Gln (factor V Leiden)
and His1299Arg substitutions in factor V. Br J Haematol. 1997;99:
257–261.
103. Delahousse B, Iochmann S, Pouplard C, Fimbel B, Charbonnier B,
Gruel Y. Pseudo-homozygous activated protein C resistance due to
coinheritance of heterozygous factor V Leiden mutation and type I
factor V deficiency: variable expression when analyzed by different
activated protein C resistance functional assays. Blood Coagul Fibrinolysis.
1997;8:503–509.
104. Lunghi B, Castoldi E, Mingozzi F, Bernardi F, Castaman G. A novel
factor V null mutation detected in a thrombophilic patient with pseudohomozygous
APC resistance and in an asymptomatic unrelated subject.
Blood. 1998;92:1463–1464.
105. de Visser MC, Rosendaal FR, Bertina RM. A reduced sensitivity for
activated protein C in the absence of factor V Leiden increases the risk
of venous thrombosis. Blood. 1999;93:1271–1276.
106. Kamphuisen PW, Rosendaal FR, Eikenboom JC, Bos R, Bertina RM.
Factor V antigen levels and venous thrombosis: risk profile, interaction
with factor V Leiden, and relation with factor VIII antigen levels.
Arterioscler Thromb Vasc Biol. 2000;20:1382–1386.
107. Ortel TL. Clinical and laboratory manifestations of anti-factor V antibodies.
J Lab Clin Med. 1999;133:326–334.
Downloaded from
http://atvb.ahajournals.org/ by guest on October 23, 2012